Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants

Показати інші версії (1)

New tuberculosis vaccines are urgently needed to curtail the current epidemic. MVA85A is a subunit vaccine that could enhance immunity from BCG vaccination. To determine MVA85A safety and immunogenicity as well as interactions with other routine vaccines administered in infancy, we randomized health...

Повний опис

Бібліографічні деталі
Автори:	Ota, M, Odutola, A, Owiafe, P, Donkor, S, Owolabi, O, Brittain, N, Williams, N, Rowland-Jones, S, Hill, A, Adegbola, R, Mcshane, H
Формат:	Journal article
Мова:	English
Опубліковано:	2011

Схожі ресурси

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
за авторством: Ota, M, та інші
Опубліковано: (2011)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
за авторством: Odutola, A, та інші
Опубліковано: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
за авторством: Odutola, A, та інші
Опубліковано: (2012)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
за авторством: Brookes, R, та інші
Опубліковано: (2008)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
за авторством: Roger H Brookes, та інші
Опубліковано: (2008-08-01)

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa.
за авторством: Roger H. Brookes, та інші
Опубліковано: (2011-01-01)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
за авторством: Rowland, R, та інші
Опубліковано: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
за авторством: Pathan, A, та інші
Опубліковано: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
за авторством: Pathan, A, та інші
Опубліковано: (2012)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
за авторством: Owiafe, P, та інші
Опубліковано: (2012)

Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design.
за авторством: Ibanga, H, та інші
Опубліковано: (2006)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
за авторством: Whelan, K, та інші
Опубліковано: (2009)

Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.
за авторством: Imoukhuede, E, та інші
Опубліковано: (2006)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
за авторством: Harris, S, та інші
Опубліковано: (2011)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
за авторством: Sander, C, та інші
Опубліковано: (2009)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
за авторством: Meyer, J, та інші
Опубліковано: (2013)

Safety and immunogenicity of malaria vectored vaccines given with routine EPI vaccines in Gambian infants and neonates: a randomized controlled trial
за авторством: Mensah, V, та інші
Опубліковано: (2017)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
за авторством: Meyer, J, та інші
Опубліковано: (2013)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
за авторством: Hawkridge, T, та інші
Опубліковано: (2008)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
за авторством: Kathryn T. Whelan, та інші
Опубліковано: (2011-01-01)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
за авторством: Rowland, R, та інші
Опубліковано: (2013)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
за авторством: Mcshane, H
Опубліковано: (2008)

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.
за авторством: White, A, та інші
Опубліковано: (2013)

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
за авторством: Scriba, T, та інші
Опубліковано: (2011)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
за авторством: Mcshane, H, та інші
Опубліковано: (2005)

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
Опубліковано: (2011-01-01)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
за авторством: Mcshane, H, та інші
Опубліковано: (2016)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
за авторством: Minassian, A, та інші
Опубліковано: (2011)

Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.
за авторством: Mullarkey, C, та інші
Опубліковано: (2013)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naive subjects gives comparable immunogenicity to one dose in ART+ subjects
за авторством: Dieye, T, та інші
Опубліковано: (2013)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
за авторством: Thomas, Z, та інші
Опубліковано: (2014)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
за авторством: de Cassan, S, та інші
Опубліковано: (2010)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.
за авторством: Fletcher, H, та інші
Опубліковано: (2008)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
за авторством: Satti, I, та інші
Опубліковано: (2014)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial
за авторством: Satti, I, та інші
Опубліковано: (2014)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
за авторством: Wajja, A, та інші
Опубліковано: (2017)

The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-gamma producing cells ex vivo.
за авторством: Ota, M, та інші
Опубліковано: (2007)

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses
за авторством: Antrobus, R, та інші
Опубліковано: (2014)

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses.
за авторством: Antrobus, R, та інші
Опубліковано: (2014)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
за авторством: Anne Wajja, та інші
Опубліковано: (2017-05-01)